BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
Religare maintains buy on Divis Laboratories
Divis Lab's Q3 earnings were below estimates due to deferred shipments to Q4. However newly announced capital expenditure plan of Rs 750 crore imparts strong visibility for next 2-3 years supporting 23 per cent earnings growth rate over FY15-18.